555 related articles for article (PubMed ID: 19175892)
21. Costs associated with persistent allergic rhinitis are reduced by levocetirizine.
Bousquet J; Demarteau N; Mullol J; van den Akker-van Marle ME; Van Ganse E; Bachert C;
Allergy; 2005 Jun; 60(6):788-94. PubMed ID: 15876309
[TBL] [Abstract][Full Text] [Related]
22. Clinical assessment of levocetirizine and budesonide in treatment of persistent allergic rhinitis regarding to symptom severity.
Kulapaditharom B; Pornprasertsuk K; Boonkitticharoen V
J Med Assoc Thai; 2010 Feb; 93(2):215-23. PubMed ID: 20302004
[TBL] [Abstract][Full Text] [Related]
23. Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study.
Kapp A; Pichler WJ
Int J Dermatol; 2006 Apr; 45(4):469-74. PubMed ID: 16650180
[TBL] [Abstract][Full Text] [Related]
24. Cetirizine reduces cytokines and inflammatory cells in children with perennial allergic rhinitis.
Ciprandi G; Tosca MA; Milanese M; Ricca V
Eur Ann Allergy Clin Immunol; 2004 Jun; 36(6):237-40. PubMed ID: 15329007
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the effect of Lactobacillus paracasei (HF.A00232) in children (6-13 years old) with perennial allergic rhinitis: a 12-week, double-blind, randomized, placebo-controlled study.
Lin WY; Fu LS; Lin HK; Shen CY; Chen YJ
Pediatr Neonatol; 2014 Jun; 55(3):181-8. PubMed ID: 24269033
[TBL] [Abstract][Full Text] [Related]
26. Comparative efficacy of cetirizine and levocetirizine in chronic idiopathic urticaria.
Garg G; Thami GP
J Dermatolog Treat; 2007; 18(1):23-4. PubMed ID: 17365263
[TBL] [Abstract][Full Text] [Related]
27. Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis.
Ciebiada M; Górska-Ciebiada M; DuBuske LM; Górski P
Ann Allergy Asthma Immunol; 2006 Nov; 97(5):664-71. PubMed ID: 17165277
[TBL] [Abstract][Full Text] [Related]
28. A 12-week placebo-controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis.
Fantin S; Maspero J; Bisbal C; Agache I; Donado E; Borja J; Mola O; Izquierdo I;
Allergy; 2008 Jul; 63(7):924-31. PubMed ID: 18588560
[TBL] [Abstract][Full Text] [Related]
29. Long term treatment with montelukast and levocetirizine combination in persistent allergic rhinitis: review of recent evidence.
Adsule SM; Misra D
J Indian Med Assoc; 2010 Jun; 108(6):381-2. PubMed ID: 21121394
[TBL] [Abstract][Full Text] [Related]
30. Comparison of cetirizine-pseudoephedrine and placebo in patients with seasonal allergic rhinitis and concomitant mild-to-moderate asthma: randomized, double-blind study.
Nathan RA; Finn AF; LaForce C; Ratner P; Chapman D; de Guia EC; Hewlett D; Kramer B
Ann Allergy Asthma Immunol; 2006 Sep; 97(3):389-96. PubMed ID: 17042147
[TBL] [Abstract][Full Text] [Related]
31. Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine.
Ciebiada M; Ciebiada MG; Kmiecik T; DuBuske LM; Gorski P
J Investig Allergol Clin Immunol; 2008; 18(5):343-9. PubMed ID: 18973097
[TBL] [Abstract][Full Text] [Related]
32. Pathophysiology of nasal obstruction and meta-analysis of early and late effects of levocetirizine.
Patou J; De Smedt H; van Cauwenberge P; Bachert C
Clin Exp Allergy; 2006 Aug; 36(8):972-81. PubMed ID: 16911353
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.
Kuna P; Bachert C; Nowacki Z; van Cauwenberge P; Agache I; Fouquert L; Roger A; Sologuren A; Valiente R;
Clin Exp Allergy; 2009 Sep; 39(9):1338-47. PubMed ID: 19438584
[TBL] [Abstract][Full Text] [Related]
34. Nasal nitric oxide and nasal eosinophils decrease with levocetirizine in subjects with perennial allergic rhinitis.
Bautista AP; Eisenlohr CP; Lanz MJ
Am J Rhinol Allergy; 2011; 25(6):383-7. PubMed ID: 22185740
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study.
Zuberbier T; Oanta A; Bogacka E; Medina I; Wesel F; Uhl P; Antépara I; Jáuregui I; Valiente R;
Allergy; 2010 Apr; 65(4):516-28. PubMed ID: 19860762
[TBL] [Abstract][Full Text] [Related]
36. A direct comparison of the efficacy of antihistamines in SAR and PAR: randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit - the Vienna Challenge Chamber (VCC).
Stübner P; Zieglmayer R; Horak F
Curr Med Res Opin; 2004 Jun; 20(6):891-902. PubMed ID: 15200748
[TBL] [Abstract][Full Text] [Related]
37. A review of the role of levocetirizine as an effective therapy for allergic disease.
Walsh GM
Expert Opin Pharmacother; 2008 Apr; 9(5):859-67. PubMed ID: 18345961
[TBL] [Abstract][Full Text] [Related]
38. Levocetirizine in the treatment of allergic diseases.
Scordamaglia F; Compalati E; Baiardini I; Scordamaglia A; Canonica GW
Expert Opin Pharmacother; 2009 Oct; 10(14):2367-77. PubMed ID: 19663743
[TBL] [Abstract][Full Text] [Related]
39. Evidence for clinical safety, efficacy, and parent and physician perceptions of levocetirizine for the treatment of children with allergic disease.
Pampura AN; Papadopoulos NG; Spičák V; Kurzawa R
Int Arch Allergy Immunol; 2011; 155(4):367-78. PubMed ID: 21346367
[TBL] [Abstract][Full Text] [Related]
40. Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation.
Kurowski M; Kuna P; Górski P
Allergy; 2004 Mar; 59(3):280-8. PubMed ID: 14982509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
